Kyverna Therapeutics, Inc.
KYTX
$9.40
$0.040.43%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 279.25M | 171.14M | 211.68M | 242.65M | 285.98M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 7.30M | 3.79M | 2.65M | 5.00M | 4.62M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 100.00K | -- | -- | -- | -- |
| Total Current Assets | 282.95M | 174.93M | 214.33M | 247.65M | 290.60M |
|
|
|||||
| Total Current Assets | 282.95M | 174.93M | 214.33M | 247.65M | 290.60M |
| Net Property, Plant & Equipment | 5.42M | 6.32M | 7.58M | 8.80M | 10.66M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 5.45M | 5.91M | 4.60M | 4.20M | 3.39M |
| Total Assets | 293.83M | 187.16M | 226.51M | 260.66M | 304.65M |
|
|
|||||
| Total Accounts Payable | 5.31M | 3.02M | 9.92M | 8.47M | 4.62M |
| Total Accrued Expenses | 27.21M | 27.17M | 26.30M | 21.24M | 25.19M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.97M | 3.69M | 3.58M | 3.59M | 3.94M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 36.49M | 33.87M | 39.79M | 33.29M | 33.76M |
|
|
|||||
| Total Current Liabilities | 36.49M | 33.87M | 39.79M | 33.29M | 33.76M |
| Long-Term Debt | 24.74M | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 320.00K | 1.34M | 2.34M | 3.35M | 4.30M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 61.55M | 35.21M | 42.13M | 36.65M | 38.06M |
|
|
|||||
| Common Stock & APIC | 657.01M | 538.94M | 534.63M | 532.17M | 530.00M |
| Retained Earnings | -424.83M | -387.02M | -350.24M | -308.16M | -263.52M |
| Treasury Stock & Other | 97.00K | 29.00K | -20.00K | -1.00K | 105.00K |
| Total Common Equity | 232.28M | 151.95M | 184.38M | 224.01M | 266.59M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 232.28M | 151.95M | 184.38M | 224.01M | 266.59M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 232.28M | 151.95M | 184.38M | 224.01M | 266.59M |
|
|
|||||